INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on tough liver cancer
Disease control OngoingThis study is testing whether adding immunotherapy drugs to a standard targeted radiation treatment helps control advanced bile duct cancer that starts in the liver. It will involve about 50 adults whose cancer cannot be removed by surgery. Patients will receive the radiation tre…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Implanted pump targets liver cancer with chemo
Disease control OngoingThis study is testing the safety of a special implanted pump and catheter system. The system delivers chemotherapy directly to the liver for adults with colorectal cancer or a type of bile duct cancer that has spread to the liver. The goal is to see if this method of delivering t…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Ronald DeMatteo, M.D. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Two-Drug attack on tough liver cancer
Disease control OngoingThis study is testing whether combining two drugs, atezolizumab and derazantinib, can help control advanced bile duct cancer that has a specific genetic feature called an FGFR2 fusion. It is for adults who have had at most one prior treatment. The main goal is to see how many pat…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Three-Drug attack before surgery aims to stop deadly liver Cancer's return
Disease control OngoingThis study is testing a new three-drug combination given before surgery for a type of aggressive liver cancer called intrahepatic cholangiocarcinoma. The goal is to shrink tumors and lower the very high chance of the cancer coming back after surgery. Researchers will compare this…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Doctors look back at radiation bead treatment for liver cancer
Knowledge-focused TerminatedThis study aimed to look back at the medical records of patients with a specific type of liver cancer (intrahepatic cholangiocarcinoma) who were treated with a procedure called radioembolization. The goal was to understand the outcomes, risks, and benefits of this treatment by co…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC